Axis Clinicals Limited

Axis Clinicals Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U73100TG2007PLC052813 Incorporated 17 February 2007 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹386.63 Cr
▼ 6% YoY
Net profit · FY 2025
₹2.95 Cr
Net margin 0.8%
EBITDA · FY 2025
₹94.91 Cr
EBITDA margin 24.5%
Authorised capital
₹183.33 Cr
Registered with MCA
Paid-up capital
₹180.36 Cr
Issued & subscribed
Open charges
₹1,256.45 Cr
Satisfied ₹517.22 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
528
Provident fund records

About Axis Clinicals Limited

Data last updated:

Axis Clinicals Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 17 February 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2007PLC052813. Its GSTIN is 36AAHCA9013B1Z3 (Telangana). The company holds 9 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹183.33 Cr and a paid-up capital of ₹180.36 Cr. It was formerly known as Penaka Holdings Private Limited and Penaka Life Sciences Private Limited. It is led by directors including Jayachandra Reddy Atluri (Whole-Time Director) and Panibhushan Reddy Bonga (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1 – 121/1 Sy. Nos.66 (Part) & 67 (Part) Miyapur Serilingampally, Hyderabad, Telangana, India – 500049.

As per the financials filed for FY 2025, the company reported a revenue of ₹386.63 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹2.95 Cr (net margin 0.8%) and EBITDA of ₹94.91 Cr (EBITDA margin 24.5%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 6% over five years.

The company has about 528 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 1 brand: AXIS Clinicals. As per MCA filings, the company has open charges of ₹1,256.45 Cr and satisfied charges of ₹517.22 Cr on record. Court records list 10 cases involving the company, including 9 filed by the company and 1 filed against it; 2 cases are pending. The company has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.99 Cr; the latest was in January 2017. Its 10 peer companies in the Pharma industry (Contract Research) are compared by revenue, 5 larger and 5 smaller; the largest is Hyclone Life Sciences Solutions India Private Limited. The company has 5 MSME Form 1 returns on record between 2018 and 2021, listing 140 overdue payments to 16 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website axisclinicals.com.

Company Details of Axis Clinicals Limited
CIN U73100TG2007PLC052813
Registration Number 052813
Incorporation Date 17 February 2007
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Jayachandra Reddy Atluri Whole-Time Director Panibhushan Reddy Bonga Whole-Time Director Lakshmi Vara Koka Additional Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    axisclinicals.com
  • Social Media
  • Registered Address
    1 – 121/1 Sy. Nos.66 (Part) & 67 (Part) Miyapur Serilingampally, Hyderabad, Telangana, India – 500049
  • Industry
    Pharma, Pharma Contract R&D
Comprehensive company report
Axis Clinicals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Axis Clinicals Limited report

Financials, compliance, directors, charges, ownership and filings for Axis Clinicals Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Axis Clinicals Limited

The main business activity of Axis Clinicals is professional, scientific and technical. In detail, this covers architecture, engineering activities, technical testing and analysis activities.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
MProfessional, Scientific and TechnicalM4Architecture, engineering activities, technical testing and analysis activitiesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Axis Clinicals Limited FY 2025 filings available

Axis Clinicals Limited reported revenue of ₹386.63 Cr (down 6% YoY) for FY 2025.

Revenue · FY 2025
₹386.63 Cr ▼ 6%
Net profit · FY 2025
₹2.95 Cr margin 0.8%
EBITDA · FY 2025
₹94.91 Cr margin 24.5%

Compounded Annual Growth Rate (CAGR) of Axis Clinicals Limited

Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▼ 8%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▼ 13%
3 years · compounded
▼ 17%

Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA fell 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Axis Clinicals Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹94.91 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹2.95 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Axis Clinicals Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin24.5%••••••••••••••••
Net Profit Margin0.8%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Axis Clinicals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Axis Clinicals Limited

Axis Clinicals Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research). Revenue, net profit, margin and growth of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Hyclone Life Sciences Solutions India Private Limited••••••••••••••••578Bangalore, Karnataka, India
Fortrea Development India Private Limited••••••••••••••••-Bangalore North, Karnataka, India
TCG Lifesciences Private Limited••••••••••••••••7,939Kolkata, West Bengal, India
PPD Pharmaceutical Development India Private Limited••••••••••••••••-Mumbai, Maharashtra, India
Biophore India Pharmaceuticals Private Limited••••••••••••••••664Hyderabad, Telangana, India
Axis Clinicals Limited this company••••••••••••••••-Hyderabad, Telangana, India
Syngene Scientific Solutions Limited••••••••••••••••-Bangalore South, Karnataka, India
Curia India Private Limited••••••••••••••••-Hyderabad, Telangana, India
Adgyl Lifesciences Private Limited••••••••••••••••259Bengaluru, Karnataka, India
Orbicular Pharmaceutical Technologies Private Limited••••••••••••••••225Hyderabad, Telangana, India
Ncsi Technologies (India) Private Limited••••••••••••••••-Pune, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Axis Clinicals by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.

Auditor Details of Axis Clinicals Limited

Axis Clinicals Limited is audited by K. Nagaraju & Associates for the financial year 2023.

NameStatusAppointment DateCessation Date
K. Nagaraju & AssociatesLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Axis Clinicals Limited

Axis Clinicals has 6 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Lakshmi Vara Koka
Also directs: Trident Chemphar Limited, Shreas Industries Limited
Additional Director30 Oct 20241 Years 11 MonthsCurrent
Jayachandra Reddy Atluri
Also directs: Clini Vigil Pharma Solutions Private Limited
Whole-Time Director06 Jul 200917 Years 3 MonthsCurrent
Panibhushan Reddy BongaWhole-Time Director06 Jul 200917 Years 3 MonthsCurrent
Mallikarjuna Reddy KantabathuniDirector06 Jul 200917 Years 3 MonthsCurrent
China Venka Reddy Kotta
Also directs: Trident Chemphar Limited, Shreas Industries Limited, C V Reddy K & Associates Private Limited and 1 more
Director07 Apr 20251 Years 6 MonthsCurrent
Naga Venkata Kesavarapu
Also directs: Trident Chemphar Limited, Shreas Industries Limited, Auro Peptides Limited and 2 more
Director07 Apr 20251 Years 6 MonthsCurrent
View all directors

Ownership and Shareholding of Axis Clinicals Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Axis Clinicals Limited

Open charges
₹1,256.45 Cr
Satisfied charges
₹517.22 Cr
Breakdown by lending institutions
Sbicap Trustee Company Limited₹911.90 Cr
Others₹315.00 Cr
Hdfc Bank Limited₹28.20 Cr
Axis Bank Limited₹1.35 Cr
Latest charge details
DateLenderAmountStatus
28 Jan 2025Others₹40 CrOpen
10 Apr 2024Others₹175 CrOpen
13 Dec 2023Others₹100 CrOpen
13 Dec 2023Axis Bank Limited₹31 LakhOpen
31 Mar 2021Sbicap Trustee Company Limited₹911.9 CrOpen

Total charge records: 34 View all charges

Deals & Funding of Axis Clinicals Limited

Axis Clinicals Limited has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.99 Cr; the latest was in January 2017.

Total deals
6
Secondary share transfers
4
Funding rounds
2
Disclosed funding
₹1.99 Cr

Deals on record (5 of 6)

WhenDealAmountParties
Jan 2017Secondary share transferUndisclosedBuyer: RPR Sons Advisors Private Limited And Penaka Suneela Rani
Seller: an individual
May 2016Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals
Feb 2011Funding round₹35 LakhInvestors: an individual
Nov 2010Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 2 individuals
Feb 2009Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Premium access

Full deal history

All 6 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME Payment Delays by Axis Clinicals Limited

Axis Clinicals Limited has 5 MSME Form 1 returns on record between 2018 and 2021, listing 140 overdue payments to 16 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 16)

SupplierAmount dueDue sinceReported on
Thermo Fisher Scientific India Private Limited••••••••••••
an individual supplier••••••••••••
Bharat Science Apparatus Workshops••••••••••••
Clearsynth Labs Limited••••••••••••
an individual supplier••••••••••••
Premium access

Full MSME payment history

Every supplier, amount and due date from all 5 MSME Form 1 returns is in the company report.

  • Every reported supplier due
  • Amounts and due dates
  • Reasons given in each return
  • Period-by-period history

Verified entity values are shown only after access is granted.

Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.

Associated Brands with Axis Clinicals Limited

Axis Clinicals operates one associated brand: AXIS Clinicals. Each brand links to its own profile.

BrandDescriptionWebsite
AXIS Clinicals
Provides contract research organization services for clinical trials worldwide.axisclinicals.com

Employees and EPFO Compliance at Axis Clinicals Limited

Axis Clinicals Limited has a workforce of 528 employees as of Apr 08, 2024.

Employee count
528
Active EPFO establishments
1
Employee growth
-0.75%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Group Structure of Axis Clinicals Limited

Axis Clinicals has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key Subsidiaries
Company NameCINShares Held
Sanhoc Labs LimitedU24232TG2011PLC076052Locked

Showing major subsidiaries. Total: 1.

Name History of Axis Clinicals Limited

Axis Clinicals has undergone 3 name changes throughout its history. The company was previously known as Penaka Holdings Private Limited, Penaka Life Sciences Private Limited, and Axis Clinicals Private Limited. The current legal name is Axis Clinicals Limited.

Company NameStatus
Axis Clinicals LimitedCurrent
Penaka Holdings Private LimitedPrevious
Penaka Life Sciences Private LimitedPrevious
Axis Clinicals Private LimitedPrevious

CIN History of Axis Clinicals Limited

Axis Clinicals has 4 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U73100TG2007PLC052813, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U73100TG2007PLC052813Current
U40100TG2007PLC052813Previous
U67120TG2007PLC052813Previous
U67120AP2007PTC052813Previous
U67120AP2007PLC052813Previous

News related to Axis Clinicals Limited

Recent Activity on Axis Clinicals Limited

Axis Clinicals Limited has 19 board changes on record since 2009: 7 appointments and 12 cessations. The latest: China Venka Reddy Kotta was appointed as Director on 07 Apr 2025.

AGM
Axis Clinicals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 40.00 Cr registered on 28 Jan 2025 with Charge ID 101042162 was modified on 06 Jun 2025.
Appointed
China Venka Reddy Kotta was appointed as Director.
Appointed
Naga Venkata Kesavarapu was appointed as Director.
Filing
Axis Clinicals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Charu Agarwal ceased to be Company Secretary.
Charges
A charge registered on 19 Oct 2019 via Charge ID 100299232 with Standard Chartered Bank was fully satisfied on 28 Mar 2025.
Charges
A charge registered on 11 Feb 2020 via Charge ID 100324874 with Axis Bank Limited was fully satisfied on 02 Feb 2025.
Charges
A charge with Others amounted to Rs. 40.00 Cr with Charge ID 101042162 was registered on 28 Jan 2025.
Charges
A charge registered on 24 Dec 2019 via Charge ID 100311487 with Axis Bank Limited was fully satisfied on 11 Dec 2024.
Appointed
Lakshmi Vara Koka was appointed as Additional Director.
Charges
A charge registered on 30 Jan 2020 via Charge ID 100321730 with Standard Chartered Bank was fully satisfied on 24 Jun 2024.

81 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Axis Clinicals Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Axis Clinicals Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Axis Clinicals Limited

Axis Clinicals has 9 GST registrations: 2 active and 7 cancelled or inactive.

Total GSTINs
9
Active
2
Cancelled / inactive
7
GSTINStateStatusRegistered on
36AAHCA9013B1Z3TelanganaActive01 Jul 2017
24AAHCA9013B1Z8GujaratActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Axis Clinicals Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Axis Clinicals Limited

Axis Clinicals is an active public limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 17 February 2007 (19+ years old) and is registered under CIN U73100TG2007PLC052813.

Axis Clinicals reported revenue of ₹386.63 Cr for FY 2025 (down 6% YoY).

Axis Clinicals has 6 current directors:

Axis Clinicals reported a net profit of ₹2.95 Cr (net margin 0.8%) and EBITDA of ₹94.91 Cr (EBITDA margin 24.5%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Axis Clinicals is -8% over three years and 6% over five years. In the latest year (FY 2025) revenue fell 6%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Axis Clinicals is 36AAHCA9013B1Z3, registered in Telangana. The company has 9 GST registrations in all, of which 2 are active and 7 are cancelled or inactive. Other active GSTINs include 24AAHCA9013B1Z8 (Gujarat).

The CIN (Corporate Identification Number) of Axis Clinicals is U73100TG2007PLC052813. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Axis Clinicals has 10 court cases on record: 9 filed by the company and 1 filed against it. 2 are pending. Most are in the high courts.

Axis Clinicals was incorporated on 17 February 2007, making it 19+ years old. It is registered with the Registrar of Companies, Hyderabad.

Axis Clinicals has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.99 Cr; the latest was in January 2017.

The peers of Axis Clinicals by revenue are Hyclone Life Sciences Solutions India Private Limited, Fortrea Development India Private Limited, TCG Lifesciences Private Limited, PPD Pharmaceutical Development India Private Limited, Biophore India Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Contract Research).

China Venka Reddy Kotta was appointed as Director on 07 Apr 2025. Naga Venkata Kesavarapu was appointed as Director on 07 Apr 2025. Charu Agarwal ceased to be Company Secretary on 31 Mar 2025. Axis Clinicals has 19 board changes on record in total.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available